NCT02096887 Effect of Patient Education on Compliance and Cardiovascular Risk Parameters Status UNKNOWN Phase NA
NCT02096861 Demonstrate Noninferiority in Efficacy and to Assess Safety of CT-P13 in Patients With Active Crohn's Disease Status COMPLETED Phase PHASE3
NCT02092922 A Phase 2 Trial of Filanesib in Relapsed/Refractory Multiple Myeloma (AfFIRM) Status COMPLETED Phase PHASE2
NCT02092467 Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis Status COMPLETED Phase PHASE4
NCT02090400 Switching From Oral Bisphosphonates to Bazedoxifene to Evaluate Effects on Bone Mineral Density in Postmenopausal Women Status COMPLETED Phase PHASE4
NCT02085382 Randomized, Controlled Trial of Kangaroo Mother Care in Increasing the Rate of Weight Gain Among Neonates Status COMPLETED Phase PHASE3
NCT02084875 A Study To Evaluate The Effect Of Food On The Behavior Of Tofacitinib Modified Release 11 Milligram Tablets In Healthy Western And Japanese Volunteers Status COMPLETED Phase PHASE1
NCT02078752 A Study Of PF-06647263 In Patients With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT02070939 Study To Evaluate Safety And Tolerability Of Single And Multiple Ascending Doses Of PF- 06260414 In Healthy Western And Japanese Male Subjects Status COMPLETED Phase PHASE1
NCT02070289 A Study to Evaluate Safety, Toleration and Time Course of Plasma Concentration of Multiple Oral Doses of PF-06372865 in Healthy Subjects of Two AgeGroups, Aged 18-55 Years (Group 1) and Aged 56-75 Years (Group 2) Status COMPLETED Phase PHASE1
NCT02068586 Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02066909 A Study To Observe Safety And Blood Concentrations Of PF-06649751 During And Following The Oral Administration Of Multiple Doses Of PF-06649751 In Healthy Adult Western and Japanese Volunteers Status COMPLETED Phase PHASE1
NCT02065063 A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Anti-Cancer Activity of Trametinib in Combination With Palbociclib in Subjects With Solid Tumors Status COMPLETED Phase PHASE1
NCT02060370 Sunitinib Scheduling in Metastatic Renal Cell Carcinoma (mRCC) Status COMPLETED Phase PHASE2